Finally, GSEA showed that many immune-related pathways, such as the T-cell receptor signaling pathway and the chemokine signaling pathway, were enriched in patients with low PTTG1 expression in most of the cancer types (Figure 14H). The gene discussed is PTTG1; the disease is cancer.